Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred S Apple

Showing results (41-50 of 293) with videos related to

Pageof 30
Sort By:
The American Journal of Medicine|May 27, 2014
Type 2 myocardial infarction: the next frontierYader Sandoval, Stephen W Smith, Fred S Apple
Clinical Biochemistry|July 16, 2013
Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarctionVikram Palamalai, MaryAnn M Murakami, Fred S Apple
Circulation. Population Health and Outcomes|February 16, 2026
Letter by Jaffe et al Regarding Article, "Disrupting the Status Quo: Reimagining How We Use Troponin for Diagnosing Myocardial Infarction"Yader Sandoval, Fred S Apple, Allan S Jaffe
Journal of the American College of Cardiology|July 4, 2006
Biomarkers in acute cardiac disease: the present and the futureAllan S Jaffe, Luciano Babuin, Fred S Apple
Clinical Chemistry|August 28, 2004
Why we don't know the answer may be more important than the specific questionAllan S Jaffe, Fred S Apple, Luciano Babuin
Circulation|November 30, 2006
Marathoner's heart?Paul D Thompson, Fred S Apple, Alan Wu
The American Journal of Medicine|January 9, 2016
Present and Future of Cardiac Troponin in Clinical Practice: A Paradigm Shift to High-Sensitivity AssaysYader Sandoval, Stephen W Smith, Fred S Apple
Circulation|January 22, 2019
Letter by Sandoval et al Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction"Yader Sandoval, Allan S Jaffe, Fred S Apple
Clinical Chemistry|April 22, 2017
In ReplyFred S Apple, Yader Sandoval, Allan S Jaffe
Clinical Chemistry|November 30, 2011
Impact of biomarkers, proteomics, and genomics in cardiovascular diseaseFred S Apple, Stefan Blankenberg, David A Morrow
Pageof 30

Showing results (41-50 of 293) with videos related to

Sort By:
Pageof 30
The American Journal of Medicine|May 27, 2014
Type 2 myocardial infarction: the next frontierYader Sandoval, Stephen W Smith, Fred S Apple
Clinical Biochemistry|July 16, 2013
Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarctionVikram Palamalai, MaryAnn M Murakami, Fred S Apple
Circulation. Population Health and Outcomes|February 16, 2026
Letter by Jaffe et al Regarding Article, "Disrupting the Status Quo: Reimagining How We Use Troponin for Diagnosing Myocardial Infarction"Yader Sandoval, Fred S Apple, Allan S Jaffe
Journal of the American College of Cardiology|July 4, 2006
Biomarkers in acute cardiac disease: the present and the futureAllan S Jaffe, Luciano Babuin, Fred S Apple
Clinical Chemistry|August 28, 2004
Why we don't know the answer may be more important than the specific questionAllan S Jaffe, Fred S Apple, Luciano Babuin
Circulation|November 30, 2006
Marathoner's heart?Paul D Thompson, Fred S Apple, Alan Wu
The American Journal of Medicine|January 9, 2016
Present and Future of Cardiac Troponin in Clinical Practice: A Paradigm Shift to High-Sensitivity AssaysYader Sandoval, Stephen W Smith, Fred S Apple
Circulation|January 22, 2019
Letter by Sandoval et al Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction"Yader Sandoval, Allan S Jaffe, Fred S Apple
Clinical Chemistry|April 22, 2017
In ReplyFred S Apple, Yader Sandoval, Allan S Jaffe
Clinical Chemistry|November 30, 2011
Impact of biomarkers, proteomics, and genomics in cardiovascular diseaseFred S Apple, Stefan Blankenberg, David A Morrow
Pageof 30